Gainers
- Insignia Systems, Inc. ISIG shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze.
- Flotek Industries, Inc. FTK climbed 33.9% to $0.75 after the company announced it received an unsolicited indication of interest for a potential transaction for all or part of the company. Flotek's Board of Directors has engaged Piper Sandler & Co.
- Reliance Global Group, Inc. RELI jumped 25.2% to $6.65. Reliance Global Group, last week, reported pricing of $20.0 million private placement with institutional investors.
- ADDvantage Technologies Group, Inc. AEY gained 15.8% to $2.13. ADDvantage Technologies reported earnings of $0.05 per share for the fourth quarter, versus a year-ago loss of $0.09 per share.
- ImmunityBio, Inc. IBRX jumped 13.8% to $7.57. ImmunityBio was granted U.S. Patent #11,207,350 'Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer.'
- Longeveron Inc. LGVN rose 13.7% to $14.18.
- BiondVax Pharmaceuticals Ltd. BVXV shares gained 13.1% to $2.6350. The company announced the former GSK global vaccines CFO joined the BiondVax Board of Directors.
- Kandi Technologies Group, Inc. KNDI climbed 11.3% to $3.7120. Kandi Technologies Group’s wholly owned subsidiary Jiangxi Province Huiyi New Energy Co Ltd (Huiyi) has entered mass production of its lithium iron phosphate (LFP) battery IFR18650-2200mAh.
- BridgeBio Pharma, Inc. BBIO jumped 11.1% to $12.64. HC Wainwright & Co. lowered the price target on the stock from $88 to $24, while SVB Leerink cut the price target from $66 to $24. BridgeBio Pharma shares tumbled 72% on Monday after the company's phase 3 trial to treat symptomatic transthyretin amyloid cardiomyopathy did not achieve its primary endpoint.
- Gamida Cell Ltd. GMDA gained 9.6% to $2.84.
- Novavax, Inc. NVAX gained 9.5% to $172.68. Novavax confirmed earlier reports that the company and Serum Institute of India received Emergency Use Authorization for COVID-19 vaccine in India.
- Spruce Biosciences, Inc. SPRB rose 7.2% to $4.5150 after jumping 13% on Monday. Oppenheimer recently initiated coverage on the stock with an Outperform rating and a $15 price target.
- JinkoSolar Holding Co., Ltd. JKS gained 7% to $45.11 after the company's Jinko Solar subsidiary completed IPO registration with the China Securities Regulatory Commission.
Check out these big penny stock gainers and losers
Losers
- Powerbridge Technologies Co., Ltd. PBTS dipped 29.2% to $0.6589 after jumping 62% on Monday.
- Baudax Bio, Inc. BXRX shares fell 23.9% to $0.2419 after the company announced a $4.2 million registered direct offering.
- Biofrontera Inc. BFRI shares dropped 20.4% to $9.15.
- Nxt-ID, Inc. NXTD fell 18% to $3.8691 after climbing around 18% on Monday.
- Microbot Medical Inc. MBOT shares dropped 15.2% to $7.59. Microbot Medical shares jumped 65% on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
- Agrify Corporation AGFY tumbled 10.3% to $9.50.
- Fathom Digital Manufacturing Corp. FATH fell 9.6% to $8.54.
- Theseus Pharmaceuticals, Inc. THRX fell 8.8% to $11.75 after jumping over 15% on Monday.
- Context Therapeutics Inc. CNTX shares declined 8.6% to $2.8590.
- Soluna Holdings, Inc. SLNH dropped 8.6% to $11.01.
- Marathon Digital Holdings, Inc. MARA fell 8.1% to $36.21.
- American Virtual Cloud Technologies, Inc. AVCT fell 7% to $2.39 after jumping 35% on Monday.
BBIOBridgeBio Pharma Inc
$27.990.79%
BFRIBiofrontera Inc
$1.042.97%
BXRXBaudax Bio Inc Ordinary Shares
$0.0200-8.26%
CNTXContext Therapeutics Inc
$1.1416.3%
FTKFlotek Industries Inc
$7.00-4.76%
IBRXImmunityBio Inc
$2.63-1.50%
JKSJinkoSolar Holding Co Ltd
$26.003.01%
KNDIKandi Technologies Group Inc
$0.9200-%
LGVNLongeveron Inc
$1.74-1.69%
MARAMARA Holdings Inc
$20.024.00%
MBOTMicrobot Medical Inc
$0.99993.07%
NVAXNovavax Inc
$8.50-1.62%
RELIReliance Global Group Inc
$2.67-14.2%
SLNHSoluna Holdings Inc
$2.25-%
SPRBSpruce Biosciences Inc
$0.420011.3%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in